ARUP's Laboratory Test Directory
| 0070120: Prostatic Acid Phosphatase |
| Test Mnemonic: PAP | |
|
#ExistMethodology>
Methodology: Chemiluminescent Immunoassay
*ExistMethodology> #ExistPerformed> Performed: Sun-Sat *ExistPerformed> #ExistReported> Reported: Within 24 hours *ExistReported> |
| Specimen Required: | |
|
#ExistCollect>
Collect: One 4 mL SST.
*ExistCollect> #ExistTransport> Transport: 1 mL serum, frozen. (Min: 0.5 mL) Submit specimen in an ARUP Standard Transport Tube. *ExistTransport> #ExistPedCollectTransport> Pediatric Collection/Transport: 0.4 mL serum, frozen. *ExistPedCollectTransport> #ExistRemarks> Remarks: Separate specimens must be submitted when multiple tests are ordered. Allow specimen to clot completely at room temperature before centrifuging. *ExistRemarks> #ExistConditions> Unacceptable Conditions: Specimens ambient greater than 3 hours or refrigerated greater than 24 hours. *ExistConditions> #ExistStability> Stability: After separation from cells: Ambient: 3 hours; Refrigerated: 24 hours; Frozen: 6 months *ExistStability> |
|
| Reference Interval: |
| #ExistRefRange> 0.0-3.5 ng/mL *ExistRefRange> |
| Interpretive Data: | |
|
#ExistInterpData>
The Siemens Immulite® 2000 PAP chemiluminescent immunoassay method is used. Results obtained with different assay methods or kits cannot be used interchangeably. Measurement of PAP has been shown to be clinically relevant in the management of patients with prostatic adenocarcinoma. Benign prostatic hyperplasia, prostate massage, and prostatic infarction may result in elevated PAP concentrations. The PAP assay value, regardless of level, should not be interpreted as evidence for the presence or absence of malignant disease.
*ExistInterpData> |
| CPT Code(s): | |
| 84066 |